Vision loss risks in patients using popular GLP-1 medications raise concerns

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the conclusion of a retrospective study published online on Jan. 30 in JAMA Ophthalmology.

Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma

Adjuvant therapy with nivolumab (Opdivo) was feasible and safe and appeared to prolong disease-free survival (DFS) in patients with completely resected Merkel cell carcinoma (MCC),

July 15, 2023

Artificial wombs, after years in development, reach FDA review for human trials

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close

September 19, 2023

INTEGRA’s pipetting solutions help Axis Healthcare to support patients in overcoming opioid addiction

Axis Healthcare, a family-run care facility in Oklahoma, has introduced VOYAGER adjustable tip spacing pipettes from INTEGRA Biosciences into its PCR laboratory workflows.

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.